121 related articles for article (PubMed ID: 34679256)
61. Costimulatory blockade-mediated lung allograft acceptance is abrogated by overexpression of Bcl-2 in the recipient.
Okazaki M; Sugimoto S; Lai J; Kornfeld CG; Hotchkiss RS; Richardson SB; Li W; Kreisel FH; Huang HJ; Patterson GA; Krupnick AS; Gelman AE; Kreisel D
Transplant Proc; 2009; 41(1):385-7. PubMed ID: 19249562
[TBL] [Abstract][Full Text] [Related]
62. Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft Rejection.
Lerret NM; Li T; Wang JJ; Kang HK; Wang S; Wang X; Jie C; Kanwar YS; Abecassis MM; Luo X; Zhang Z
J Am Soc Nephrol; 2015 Nov; 26(11):2753-64. PubMed ID: 25788530
[TBL] [Abstract][Full Text] [Related]
63. Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host disease.
Fujiwara H; Maeda Y; Kobayashi K; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanaka T; Chen L; Azuma M; Yagita H; Tanimoto M
J Immunol; 2014 Sep; 193(5):2565-73. PubMed ID: 25080485
[TBL] [Abstract][Full Text] [Related]
64. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
Cong L; Wang SF; Zhao ZL; Yang RY
Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
[TBL] [Abstract][Full Text] [Related]
65. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts.
Koga N; Suzuki J; Kosuge H; Haraguchi G; Onai Y; Futamatsu H; Maejima Y; Gotoh R; Saiki H; Tsushima F; Azuma M; Isobe M
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2057-62. PubMed ID: 15374847
[TBL] [Abstract][Full Text] [Related]
66. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation.
Kanai T; Totsuka T; Uraushihara K; Makita S; Nakamura T; Koganei K; Fukushima T; Akiba H; Yagita H; Okumura K; Machida U; Iwai H; Azuma M; Chen L; Watanabe M
J Immunol; 2003 Oct; 171(8):4156-63. PubMed ID: 14530338
[TBL] [Abstract][Full Text] [Related]
67. Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes.
Okiyama N; Katz SI
J Autoimmun; 2014 Sep; 53():1-9. PubMed ID: 25047812
[TBL] [Abstract][Full Text] [Related]
68. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
[TBL] [Abstract][Full Text] [Related]
69. PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1.
Bodhankar S; Chen Y; Vandenbark AA; Murphy SJ; Offner H
J Neuroinflammation; 2013 Sep; 10():111. PubMed ID: 24015822
[TBL] [Abstract][Full Text] [Related]
70. Knockout of microRNA-155 ameliorates the Th1/Th17 immune response and tissue injury in chronic rejection.
Zhang A; Wang K; Zhou C; Gan Z; Ma D; Ye P; Sun Y; Wu J; Huang X; Ren L; Deng P; Wu C; Yue Z; Ding X; Chen J; Xia J
J Heart Lung Transplant; 2017 Feb; 36(2):175-184. PubMed ID: 27296836
[TBL] [Abstract][Full Text] [Related]
71. CD8+ cells are not necessary for allograft rejection or the induction of apoptosis in an experimental model of small intestinal transplantation.
Krams SM; Hayashi M; Fox CK; Villanueva JC; Whitmer KJ; Burns W; Esquivel CO; Martinez OM
J Immunol; 1998 Apr; 160(8):3673-80. PubMed ID: 9558067
[TBL] [Abstract][Full Text] [Related]
72. IP-10-induced recruitment of CXCR3 host T cells is required for small bowel allograft rejection.
Zhang Z; Kaptanoglu L; Tang Y; Ivancic D; Rao SM; Luster A; Barrett TA; Fryer J
Gastroenterology; 2004 Mar; 126(3):809-18. PubMed ID: 14988835
[TBL] [Abstract][Full Text] [Related]
73.
da Fonseca-Martins AM; de Souza Lima-Gomes P; Antunes MM; de Moura RG; Covre LP; Calôba C; Rocha VG; Pereira RM; Menezes GB; Gomes DCO; Saraiva EM; de Matos Guedes HL
Front Immunol; 2021; 12():598943. PubMed ID: 34211455
[TBL] [Abstract][Full Text] [Related]
74. Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice.
Frebel H; Nindl V; Schuepbach RA; Braunschweiler T; Richter K; Vogel J; Wagner CA; Loffing-Cueni D; Kurrer M; Ludewig B; Oxenius A
J Exp Med; 2012 Dec; 209(13):2485-99. PubMed ID: 23230000
[TBL] [Abstract][Full Text] [Related]
75. PD-L1 on mast cells suppresses effector CD8
Hirano T; Honda T; Kanameishi S; Honda Y; Egawa G; Kitoh A; Nakajima S; Otsuka A; Nomura T; Dainichi T; Yaguchi T; Inozume T; Kataoka TR; Tamada K; Kabashima K
J Allergy Clin Immunol; 2021 Aug; 148(2):563-573.e7. PubMed ID: 33581199
[TBL] [Abstract][Full Text] [Related]
76. Treatment with Anti-FcεRIα (MAR-1) Antibody Prevents Acute Islet Allograft Rejection in a Murine Model.
Yazawa N; Imaizumi T; Makuuchi H; Tsuchiya I; Tanaka M; Inokuchi S; Habu S; Nakagohri T
Tokai J Exp Clin Med; 2015 Dec; 40(4):141-8. PubMed ID: 26662664
[TBL] [Abstract][Full Text] [Related]
77. Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis.
Pittet CL; Newcombe J; Prat A; Arbour N
J Neuroinflammation; 2011 Nov; 8():155. PubMed ID: 22067141
[TBL] [Abstract][Full Text] [Related]
78. Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8
Eissa IR; Mukoyama N; Abdelmoneim M; Naoe Y; Matsumura S; Bustos-Villalobos I; Ichinose T; Miyajima N; Morimoto D; Tanaka M; Fujimoto Y; Sone M; Kodera Y; Kasuya H
Int J Cancer; 2021 Jul; 149(1):214-227. PubMed ID: 33687756
[TBL] [Abstract][Full Text] [Related]
79. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
[TBL] [Abstract][Full Text] [Related]
80. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells.
Newell KA; He G; Guo Z; Kim O; Szot GL; Rulifson I; Zhou P; Hart J; Thistlethwaite JR; Bluestone JA
J Immunol; 1999 Sep; 163(5):2358-62. PubMed ID: 10452966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
